PhRMA Comments to CMS on Plan to Amend Tennessee’s Section 1115 Demonstration

PhRMA submitted the following comments on Tennessee's plan to amend Section 1115, a plan which requests new flexibilities and certain exemptions for TennCare administrators from federal oversight. PhRMA has grave concerns about the impact the drug-related proposals would have on Medicaid beneficiaries' access to crucial medications, and urges CMS not to approve these elements of Tennessee's proposal.